Researchers have tested strategies to combine riboswitches—RNA motifs that change conformation in response to binding another molecule—with these aptamers to create biosensors that fluoresce only when ...
Principal Financial Group Inc. increased its holdings in shares of Structure Therapeutics Inc. (NASDAQ:GPCR – Free Report) by 230.0% in the third quarter, according to the company in its most recent ...